Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 279

1.

Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes.

Zhu J, Volkening LK, Laffel LM.

Diabetes Care. 2019 Jul 15. pii: dc190083. doi: 10.2337/dc19-0083. [Epub ahead of print]

PMID:
31308020
2.

Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.

Van Name MA, Miller KM, Commissariat PV, Whitehouse AL, Harrington KR, Anderson BJ, Mantravadi MG, Levy W, DeSalvo DJ, Tamborlane WV, Hilliard ME, Laffel LM, DiMeglio LA.

Diabet Med. 2019 Jul 11. doi: 10.1111/dme.14074. [Epub ahead of print]

PMID:
31295359
3.

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA.

Diabetes Technol Ther. 2019 Jul 9. doi: 10.1089/dia.2019.0142. [Epub ahead of print]

PMID:
31287721
4.

Autism spectrum disorder in children with Type 1 diabetes.

Bethin KE, Kanapka LG, Laffel LM, Majidi S, Chaytor NS, MacLeish S, Adams R, Foster NC; T1D Exchange Clinic Network.

Diabet Med. 2019 Jul 4. doi: 10.1111/dme.14069. [Epub ahead of print]

PMID:
31271682
5.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Jun 8. pii: dci190028. doi: 10.2337/dci19-0028. [Epub ahead of print]

PMID:
31177185
6.

Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.

Perkins BA, Rosenstock J, Skyler JS, Laffel LM, Cherney DZ, Mathieu C, Pang C, Wood R, Kinduryte O, George JT, Marquard J, Soleymanlou N.

Diabetes Care. 2019 Jun 8. pii: dc190548. doi: 10.2337/dc19-0548. [Epub ahead of print]

PMID:
31177179
7.

Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience.

Songer TJ, Haymond MW, Glazner JE, Klingensmith GJ, Laffel LM, Zhang P, Hirst K; TODAY Study Group.

Pediatr Diabetes. 2019 May 23. doi: 10.1111/pedi.12869. [Epub ahead of print]

PMID:
31119838
8.

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.

Bode BW, Iotova V, Kovarenko M, Laffel LM, Rao PV, Deenadayalan S, Ekelund M, Larsen SF, Danne T.

Diabetes Care. 2019 Jul;42(7):1255-1262. doi: 10.2337/dc19-0009. Epub 2019 May 10.

PMID:
31076415
9.

Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ; TODAY Study Group.

Diabetes Care. 2019 Jun;42(6):1120-1128. doi: 10.2337/dc18-2147. Epub 2019 Apr 9.

PMID:
30967435
10.

Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.

Weinstock RS, Braffett BH, McGuigan P, Larkin ME, Grover NB, Walders-Abramson N, Laffel LM, Chan CL, Chang N, Schwartzman BE, Barajas RA, Celona-Jacobs N, Haymond MW; TODAY Study Group.

Diabetes Care. 2019 May;42(5):903-909. doi: 10.2337/dc18-1854. Epub 2019 Mar 4.

PMID:
30833375
11.

Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.

Weissberg-Benchell J, Shapiro JB, Hood K, Laffel LM, Naranjo D, Miller K, Barnard K.

Diabet Med. 2019 May;36(5):644-652. doi: 10.1111/dme.13930. Epub 2019 Mar 20.

12.

Text-message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes.

McGill DE, Volkening LK, Butler DA, Wasserman RM, Anderson BJ, Laffel LM.

Diabet Med. 2019 May;36(5):600-605. doi: 10.1111/dme.13929. Epub 2019 Feb 25.

PMID:
30734361
13.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP.

Diabetes Technol Ther. 2019 Feb;21(2):73-80. doi: 10.1089/dia.2018.0308. Epub 2019 Jan 16.

PMID:
30649925
14.

Factors associated with disordered eating behaviours in adolescents with Type 1 diabetes.

Cecilia-Costa R, Volkening LK, Laffel LM.

Diabet Med. 2019 Aug;36(8):1020-1027. doi: 10.1111/dme.13890. Epub 2019 Mar 4.

PMID:
30582670
15.

The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY.

Arslanian S, El Ghormli L, Young Kim J, Bacha F, Chan C, Ismail HM, Levitt Katz LE, Levitsky L, Tryggestad JB, White NH; TODAY Study Group.

Diabetes Care. 2019 Jan;42(1):164-172. doi: 10.2337/dc18-1122. Epub 2018 Nov 19.

PMID:
30455329
16.

Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories.

Zhu J, Volkening LK, Laffel LM.

J Clin Endocrinol Metab. 2019 Jan 1;104(1):74-82. doi: 10.1210/jc.2018-01737.

PMID:
30346541
17.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.

Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, Zinman B, Skyler JS, George J, Soleymanlou N, Perkins BA.

Diabetes Care. 2018 Dec;41(12):2560-2569. doi: 10.2337/dc18-1749. Epub 2018 Oct 4.

PMID:
30287422
18.

Management of cardiovascular disease risk in teens with type 1 diabetes: Perspectives of teens with and without dyslipidemia and parents.

Katz ML, Guo Z, Cheema A, Laffel LM.

Pediatr Diabetes. 2019 Mar;20(2):210-216. doi: 10.1111/pedi.12771.

PMID:
30209870
19.

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association.

Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D.

Diabetes Care. 2018 Sep;41(9):2026-2044. doi: 10.2337/dci18-0023. Epub 2018 Aug 9. No abstract available.

PMID:
30093549
20.

ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children and adolescents with diabetes.

Laffel LM, Limbert C, Phelan H, Virmani A, Wood J, Hofer SE.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:193-204. doi: 10.1111/pedi.12741. No abstract available.

PMID:
30079506

Supplemental Content

Loading ...
Support Center